Related Experiment Video
Updated: May 13, 2026

Inner Mitochondrial Membrane Sensitivity to Na+ Reveals Partially Segmented Functional CoQ Pools
Published on: July 20, 2022
Coenzyme Q10 ameliorates the reduction in GLUT4 transporter expression induced by simvastatin in 3T3-L1 adipocytes
Shobana Ganesan1, Matthew K Ito
1Department of Pharmacy Practice, College of Pharmacy, Oregon State University/ Oregon Health & Science University, Portland, OR 97239, USA.
Background:
Statins significantly reduce cardiovascular events in a broad population of patients with hyperlipidemia. However, a small, but significant risk of new-onset diabetes has been reported in patients treated with statins. The mechanism by which statins cause diabetes has not been elucidated and therefore preventive strategies have yet to be defined.
Method:
Our goal was to study the differing effects of a lipophilic (simvastatin) statin, hydrophilic (pravastatin) statin, and ezetimibe on glucose transporter-4 (GLUT4) protein expression in 3T3-L1 adipocytes. We hypothesized that the reductions in GLUT4 protein secondary to statin treatment would be prevented when cells were co-incubated with coenzyme Q10 (CoQ10). GLUT4 protein expression was determined using the In-Cell Western technique. Confluent adipocytes were differentiated using a hormonal cocktail for 3 days; followed by treatment with simvastatin, pravastatin, ezetimibe and CoQ10. Cell morphology was observed after treatment using phase-contrast microscopy.
Results:
Treatment with simvastatin (P<0.001) and simvastatin plus ezetimibe (P<0.001) significantly decreased GLUT4 protein expression in the adipocytes compared to control conditions. GLUT4 protein levels were similar to control after treatment with ezetimibe alone (P=0.52) or pravastatin (P=0.32). There was no significant difference (P=0.098) in GLUT4 protein levels after co-treatment with CoQ10 between any of the treatments and control conditions.
Conclusion:
Our studies have shown that lipophilic statins (simvastatin) reduce the GLUT4 protein levels in adipocytes, whereas hydrophilic statins (pravastatin) or ezetimibe do not. Co-treatment with CoQ10 appears to prevent the reduction in GLUT4 protein levels caused by simvastatin.
Insights
Lipophilic statins like simvastatin reduce glucose transporter-4 (GLUT4) protein in fat cells, potentially increasing diabetes risk. Coenzyme Q10 (CoQ10) may prevent this effect, offering a new preventive strategy.
Area of Science:
- Biochemistry
- Molecular Biology
- Endocrinology
Background:
- Statins effectively lower cardiovascular events in hyperlipidemia patients.
- A subset of patients on statins develop new-onset diabetes, with unclear mechanisms.
- Understanding statin-induced diabetes mechanisms is crucial for developing preventive strategies.
Purpose of the Study:
- To investigate the differential effects of lipophilic (simvastatin) and hydrophilic (pravastatin) statins, and ezetimibe on glucose transporter-4 (GLUT4) protein expression in adipocytes.
- To determine if coenzyme Q10 (CoQ10) can prevent statin-induced reductions in GLUT4 protein.
Main Methods:
- Utilized 3T3-L1 adipocytes differentiated with a hormonal cocktail.
- Assessed GLUT4 protein expression using the In-Cell Western technique.
- Treated cells with simvastatin, pravastatin, ezetimibe, and CoQ10, individually and in combination.
Main Results:
- Simvastatin significantly decreased GLUT4 protein expression in adipocytes.
- Ezetimibe alone or pravastatin did not significantly alter GLUT4 protein levels.
- Co-treatment with CoQ10 did not significantly prevent the reduction in GLUT4 protein observed with simvastatin.
Conclusions:
- Lipophilic statins, such as simvastatin, reduce GLUT4 protein levels in adipocytes, unlike hydrophilic statins or ezetimibe.
- Coenzyme Q10 (CoQ10) co-treatment showed a trend towards preventing simvastatin-induced GLUT4 reduction, warranting further investigation.
- Findings suggest a potential mechanism for statin-induced diabetes and a possible preventive role for CoQ10.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Electron Transport Chain: Complex III and IV
Lipid Absorption
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
Lipid Catabolism
